PROFITELLIGENCE/Guest access
!
Financial disclaimer

Profitelligence provides financial data and analytics for informational purposes only. Nothing on this platform constitutes investment advice, a recommendation, or an offer to buy or sell any securities. Past performance does not guarantee future results. Always do your own research and consult a licensed financial advisor before making investment decisions.

Legal agreement

By continuing, you acknowledge that you have read and agree to our Terms of Service and Privacy Policy.

i
Guest mode

You're browsing as a guest. Some features like watchlists and alerts require a free account.

--:--:--
Guest mode— viewing CME. Sign up free to access all symbols.Sign up
CME logo

CME

CME Group Inc.

Financial ServicesFinancial Data & Stock Exchanges

Price performance

Sep 18, 2026
$276.01
+$4.86+1.79%
1M
+3.40%
3M
+12.03%
YTD
+2.35%
vs SPY
+2.02%
30d range
257–290
Volatility
21.09%
Signals
Price chart

Company activity

32 events
Company activity
TimeTickerTypeEventQtyPriceValue
09/09CME8-KCME Group Announces New Senior Leadership Appointments
08/11CME8-KCME Group Announces Pricing Changes
07/22CME8-KCME Group Reports Strong Q2 2026 Financial Results
06/17CME8-KCME Group Announces Leadership Transition with Duffy to Executive Chairman and Fitzpatrick as New CEO
06/10CME8-KCME Group Inc. Annual Meeting Results: Director Election Proposals Fail, Amendment Passes
05/19CME8-KCME Group Inc. Announces Results of 2026 Annual Meeting of Shareholders
04/27CME8-KCME Group Inc. Amends $7 Billion Credit Facility
04/22CME8-KCME Group Reports Record Q1 2026 Financial Results
02/04CME8-KCME Group Reports Record Annual Revenue and Volume for 2025
02/02CME8-KCME Group Communicates Pricing Changes to Clients
10/22/25CME8-KCME Group Reports Q3 2025 Financial Results with Adjusted Earnings Matching Prior Year
09/11/25CME8-KCME Group Announces Retirement of Chief Accounting Officer Jack Tobin
07/25/25CME8-KCME Group Wins Legal Battle Against Class B Shareholders
07/23/25CME8-KCME Group Inc. Reports Record Revenue and Earnings for Q2 2025
05/09/25CME8-KCME Group Shareholders Re-elect Directors and Approve Compensation at 2025 Annual Meeting
04/25/25CME8-KCME Group Announces New Credit Facilities
04/23/25CME8-KCME Group Reports Record Q1 2025 Financials
04/14/25CME8-KCME Group to Sell Osttra for $3.1 Billion to KKR
03/10/25CME8-KCME Group Inc. Completes $750M Notes Offering
03/04/25CME8-KCME Group Announces $750M Bond Offering
02/12/25CME8-KCME Group Reports Record Annual Revenue and Earnings for 2024
12/11/24CME8-KCME Group Inc. Announces Changes to Clearing House Collateral Fee Schedule and Pricing
12/05/24CME8-KCME Group Announces $3 Billion Share Repurchase Program and $2.1 Billion Annual Dividend
11/07/24CME8-KCME Group Extends Chairman and CEO's Employment Agreement, Announces Key Leadership Changes
10/23/24CME8-KCME Group Reports Record Financial Results for Q3 2024
07/24/24CME8-KCME Group Reports Record Q2 2024 Financial Results
07/08/24CME8-KCME Group Appoints Mike Dennis as Global Head of Fixed Income, Dennis Resigns from Board
05/13/24CME8-KCME Group Inc. Announces Results of 2024 Annual Meeting of Shareholders
04/25/24CME8-KCME Group Inc. Announces Amendment to Credit Facility
04/24/24CME8-KCME Group Reports First-Quarter 2024 Financial Results with Adjusted Earnings Beat
03/07/24CME8-KCME Group Inc. Announces Amendments to Stock Plan
02/14/24CME8-KCME Group Reports Record Annual Results for 2023 with Strong Interest Rate Product Performance

CME filing record

CME Group Inc. (CME): 32 8-K filings summarized, the most recent on Sep 9, 2026.

What the 8-K filings said

  1. Sep 9, 2026 · high impact

    CME Group, the world's leading derivatives marketplace, announced new senior leadership appointments in its finance and legal divisions. Jack Tobin will be promoted to Chief Financial Officer, effective March 2027, after serving as Deputy Chief Financial Officer starting November 2026. Matthew Render will succeed…

    CME Group Announces New Senior Leadership Appointments
  2. Aug 11, 2026 · high impact

    On August 11, 2026, CME Group Inc. disclosed pricing changes to its clients via Special Executive Report No. 9799, as required under Regulation FD. A copy of this notice has been posted to the Company's website.

    CME Group Announces Pricing Changes
  3. Jul 22, 2026 · high impact

    CME Group Inc. reported strong financial results for the second quarter of 2026, with revenue of $1.7 billion, operating income of $1.1 billion, and net income of $1.0 billion. Diluted earnings per common share were $2.88 on a GAAP basis and $2.99 on an adjusted basis. The company also reported a record $238 million…

    CME Group Reports Strong Q2 2026 Financial Results
  4. Jun 17, 2026 · high impact

    CME Group Inc. announced on June 17, 2026, that Terrence A. Duffy, its current Chairman and Chief Executive Officer, will transition to the role of Executive Chairman, effective March 1, 2027. Lynne C. Fitzpatrick, the current President and Chief Financial Officer, will succeed Duffy as the new Chief Executive Officer…

    CME Group Announces Leadership Transition with Duffy to Executive Chairman and Fitzpatrick as New CEO
  5. Jun 10, 2026 · high impact

    CME Group Inc. held its 2026 Annual Meeting of Shareholders on June 9, 2026. Proposals to eliminate the right of Class B-1, B-2, and B-3 shareholders to elect directors did not pass. However, an amendment to the certificate of incorporation passed, though it will not be filed due to the failure of other proposals.…

    CME Group Inc. Annual Meeting Results: Director Election Proposals Fail, Amendment Passes

SEC filings in the last five years

  • 53 Form 8-K
  • 13 Form 10-Q
  • 5 Form 10-K